Literature DB >> 20838830

Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children.

Jerzy Konstantynowicz1, Dariusz M Lebensztejn, Elzbieta Skiba, Maria E Sobaniec-Lotowska, Pawel Abramowicz, Janina Piotrowska-Jastrzebska, Maciej Kaczmarski.   

Abstract

Chronic liver disease in adults is a risk factor of osteoporosis, but little is known about risk of fractures in children with non-cholestatic liver disease. The aim of this study was to investigate associations among the severity of liver fibrosis, bone mass and low-energy fractures in children. History of fractures, anthropometry, and bone mass and size were examined in 39 Caucasian children (25 boys, 14 girls) aged 7.1-18 years (mean 11.9 ± 3.1) with chronic hepatitis B and liver fibrosis evidenced by liver biopsy. Severity of liver fibrosis was based on histological classification according to the method of Batts and Ludwig (mild, 1-2 scores; advanced, 3 scores) and Ishak (1-3 and 4-5 scores, respectively). Bone mineral content (BMC), density (BMD) and body composition were determined in the total body and lumbar spine using dual energy X-ray absorptiometry. Seven subjects (4 girls, 3 boys; 18% of the sample) had low BMD in the total body and lumbar spine region (Z-scores below -2.0). No associations were found among BMC, BMD, bone size and the severity of liver fibrosis. Nine boys (36% of all boys) and one girl reported repeated fractures (forearm, wrist, tibia, ankle, humerus), showing trends similar to the prevalence in general population. Fractures were neither associated with lower BMD/BMC nor with scores of liver fibrosis. Deficits in BMD in children with chronic hepatitis B are not associated with the severity of liver fibrosis. This study suggests that non-cholestatic liver disease does not increase the risk of low-energy fractures during growth. From the practical perspective, however, children with chronic liver disease should be screened for history and clinical risk factors for fractures rather than referred to bone density testing.

Entities:  

Mesh:

Year:  2010        PMID: 20838830     DOI: 10.1007/s00774-010-0219-7

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  36 in total

1.  Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference.

Authors:  Sanford Baim; Mary B Leonard; Maria-Luisa Bianchi; Didier B Hans; Heidi J Kalkwarf; Craig B Langman; Frank Rauch
Journal:  J Clin Densitom       Date:  2008 Jan-Mar       Impact factor: 2.617

2.  Prevalence and prediction of osteopenia in chronic liver disease.

Authors:  H L Bonkovsky; M Hawkins; K Steinberg; T Hersh; J T Galambos; J M Henderson; W J Millikan; J R Galloway
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

3.  Osteodystrophy in patients with chronic hepatitis and liver cirrhosis.

Authors:  K Tsuneoka; Y Tameda; K Takase; T Nakano
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

Review 4.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

5.  Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis.

Authors:  R Olsson; C Johansson; G Lindstedt; D Mellström
Journal:  Scand J Gastroenterol       Date:  1994-08       Impact factor: 2.423

6.  Epidemiology of children's fractures.

Authors:  L A Landin
Journal:  J Pediatr Orthop B       Date:  1997-04       Impact factor: 1.041

7.  Increasing incidence of distal radius fractures in Japanese children and adolescents.

Authors:  H Hagino; K Yamamoto; H Ohshiro; T Nose
Journal:  J Orthop Sci       Date:  2000       Impact factor: 1.601

8.  Bone mineral density among cirrhotic patients awaiting liver transplantation.

Authors:  Rana Paramvir Sokhi; Abhinandana Anantharaju; Ravi Kondaveeti; Steven D Creech; Khondker K Islam; David H Van Thiel
Journal:  Liver Transpl       Date:  2004-05       Impact factor: 5.799

9.  Bone mineral density and disorders of mineral metabolism in chronic liver disease.

Authors:  Joe George; Hosahithlu K Ganesh; Shrikrishna Acharya; Tushar R Bandgar; Vyankatesh Shivane; Anjana Karvat; Shobna J Bhatia; Samir Shah; Padmavathy S Menon; Nalini Shah
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

10.  Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

Authors:  Ali Gur; Bünyamin Dikici; Kemal Nas; Mehmet Bosnak; Kenan Haspolat; Aysegul Jale Sarac
Journal:  BMC Gastroenterol       Date:  2005-09-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.